Text Size

Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease – A randomised comparative study

Amrane M., Creuzot-Garcher C., Robert P.-Y., Ismail D., Garrigue J.-S., Pisella P.-J., Baudouin C.


  • 2014
  • Journal Francais d'Ophtalmologie
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Santen SAS, 1, rue Pierre-Fontaine, Evry cedex, 91058, France; Service D'ophtalmologie, CHU de Dijon, 3, rue du Faubourg-Raines, Dijon, 21000, France; Service D'ophtalmologie, CHU Dupuytren, 2, avenue Martin-Luther-King, Limoges, 87000, France; Service D'ophtalmologie, CHU Bretonneau, 2, boulevard Tonnellé, Tours, 37000, France; Service D'ophtalmologie, Centre National D'ophtalmologie des Quinze-Vingts, Institut de la Vision, 28, rue de Charenton, Paris, 75012, France; Hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, Boulogne-Billancourt, 92100, France; Université de Versailles Saint-Quentin-en-Yvelines, 55, avenue de Paris, Versailles, 78000, France

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022